Qianhai Health Holdings Ltd. (HK:0911)
:0911
Want to see HK:0911 full AI Analyst Report?
0911 Stock Chart & Stats
HK$0.28
-HK$0.03(-8.77%)
At close: 4:00 PM EST
HK$0.28
-HK$0.03(-8.77%)
Day’s Range― - ―
52-Week RangeHK$0.13 - HK$1.40
Previous CloseN/A
Volume500.00
Average Volume (3M)199.38K
Market Cap
HK$140.64M
Enterprise ValueHK$79.68M
Total Cash (Recent Filing)HK$61.38M
Total Debt (Recent Filing)HK$424.00K
Price to Earnings (P/E)7.8
Beta-0.15
Next Earnings
Aug 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding169,445,000
10 Day Avg. Volume241,207
30 Day Avg. Volume199,376
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.12
Price to Sales (P/S)0.07
P/FCF Ratio1.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low Leverage / Strong Balance SheetExtremely low leverage provides durable financial flexibility and materially reduces refinancing and solvency risk. With negligible debt, the company can fund operations, absorb shocks or invest selectively without urgent external financing, supporting stability over the next 2–6 months.
Improved Cash GenerationMaterially stronger operating and free cash flow in 2025 indicates real cash conversion and reduces reliance on external capital. Reliable FCF supports organic investment, working capital needs and selective strategic initiatives, improving resilience and funding optionality over coming months.
Revenue Rebound And Return To ProfitabilityA sharp revenue rebound and restored profitability show renewed market traction and improved commercial execution. This re-establishes a growth base and the potential for scale benefits, making near-term revenue momentum a durable tailwind if cost structure is controlled.
Bears Say
Very Thin MarginsExtremely low gross and net margins leave minimal operating buffer and limit reinvestment capacity. Thin margins make profitability highly sensitive to input cost or pricing shifts and constrain long-term return on capital unless gross economics materially improve.
Margin Compression / Fragile RecoveryObserved margin compression versus the prior year and an explicit 'fragile' recovery signal heightened execution and competitive risk. Small adverse moves in costs or pricing could rapidly reverse earnings progress, reducing predictability of results over the medium term.
Historic Volatility And Low Capital EfficiencyA history of multi-year cash burn and deep losses, combined with modest ROE after recovery, indicates volatile profit generation and limited capital efficiency. That track record raises execution risk and suggests returns may remain constrained absent structural improvement.
Qianhai Health Holdings Ltd. News
0911 FAQ
What was Qianhai Health Holdings Ltd.’s price range in the past 12 months?
Qianhai Health Holdings Ltd. lowest stock price was HK$0.13 and its highest was HK$1.40 in the past 12 months.
What is Qianhai Health Holdings Ltd.’s market cap?
Qianhai Health Holdings Ltd.’s market cap is HK$140.64M.
When is Qianhai Health Holdings Ltd.’s upcoming earnings report date?
Qianhai Health Holdings Ltd.’s upcoming earnings report date is Aug 25, 2026 which is in 96 days.
How were Qianhai Health Holdings Ltd.’s earnings last quarter?
Qianhai Health Holdings Ltd. released its earnings results on Mar 18, 2026. The company reported HK$0.007 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.007.
Is Qianhai Health Holdings Ltd. overvalued?
According to Wall Street analysts Qianhai Health Holdings Ltd.’s price is currently Overvalued.
Does Qianhai Health Holdings Ltd. pay dividends?
Qianhai Health Holdings Ltd. pays a Notavailable dividend of HK$0.1 which represents an annual dividend yield of N/A. See more information on Qianhai Health Holdings Ltd. dividends here
What is Qianhai Health Holdings Ltd.’s EPS estimate?
Qianhai Health Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qianhai Health Holdings Ltd. have?
Qianhai Health Holdings Ltd. has 169,445,000 shares outstanding.
What happened to Qianhai Health Holdings Ltd.’s price movement after its last earnings report?
Qianhai Health Holdings Ltd. reported an EPS of HK$0.007 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Qianhai Health Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:0911
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Qianhai Health Holdings Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.52%
12-Months-Change
Fundamentals
Return on Equity
0.91%
Trailing 12-Months
Asset Growth
0.26%
Trailing 12-Months
Company Description
Qianhai Health Holdings Ltd.
Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products and electronic component products in Hong Kong. The company operates through Health-Care Products and Electronic Component Products segments. It offers Chinese herbal medicines, and skincare and other health-care products to wholesalers and retailers, as well as American ginseng, a perennial plant. The company is also involved in the sale of electronic components, including central processing unit, semi-conductor, etc. In addition, it engages in the trading of health-care products and electronic components; and money lending business. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Explorer Rosy Limited.
Technical Analysis
Extrawell Pharmaceutical Holdings Limited
―
Tianda Pharmaceuticals Ltd.
―
Wai Yuen Tong Medicine Holdings Limited
―
PuraPharm Corp. Ltd.
―
Jacobson Pharma Corporation Limited
―